Form 4: Praxis Precision Medicines Executive Acquires Stock Options and Restricted Stock Units

Lauren Mastrocola, Principal Accounting Officer at Praxis Precision Medicines, received stock options and restricted stock units, and also had shares withheld for tax obligations.

Summary

• Lauren Mastrocola, the Principal Accounting Officer of Praxis Precision Medicines, was granted 5,000 restricted stock units on January 10, 2025.
• These restricted stock units vest annually over four years, starting on January 10, 2026.
• Ms. Mastrocola also received stock options for 10,000 shares, vesting over four years with 25% vesting on January 10, 2026, and the remaining 75% vesting monthly thereafter.
• On January 12, 2025, 390 shares were withheld by the company to cover tax obligations related to previously vested restricted stock units.
• The price of the shares withheld for tax was $63.15.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally positive for aligning management and shareholder interests. There are no negative implications.

Positives

• The grant of restricted stock units and stock options to a key executive aligns her interests with the company's long-term performance.
• The vesting schedule of the stock options and restricted stock units encourages long-term commitment from the executive.

Risks

• The vesting of the stock options and restricted stock units is contingent on the executive's continued service, which could be a risk if she leaves the company.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a standard practice for publicly traded companies to incentivize and retain key executives through equity-based compensation.

Comparison to Industry Standards

• Equity grants are a common form of compensation for executives in the biotechnology industry, aligning their interests with shareholders.
• The vesting schedules described are typical for stock options and restricted stock units, encouraging long-term commitment.
• The tax withholding process is standard practice for equity compensation.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of management's commitment to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, insider trading, executive compensation, Praxis Precision Medicines, equity